Table 3.
Comorbid disorders
| Comorbid disorder | Overall (N = 7307) |
Female patients (n = 6847) |
Male patients (n = 460) |
Odds ratio | 95% CI | |||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |||
| Migraine | 2901 | 39.7 | 2801 | 40.9 | 100 | 21.7 | 2.5 | 2.0–3.1 |
| Irritable bowel syndrome | 2185 | 29.9 | 2107 | 30.8 | 78 | 17.0 | 2.2 | 1.7–2.8 |
| Ehlers-Danlos syndrome | 1796 | 24.2 | 1724 | 25.2 | 72 | 15.7 | 1.8 | 1.4–2.3 |
| Asthma | 1540 | 21.1 | 1472 | 21.5 | 68 | 14.8 | 1.6 | 1.2–2.1 |
| Chronic fatigue syndrome | 1453 | 19.9 | 1387 | 20.3 | 66 | 14.3 | 1.5 | 1.2–2.0 |
| Fibromyalgia | 1367 | 18.7 | 1330 | 19.4 | 37 | 8.0 | 2.8 | 2.0–2.9 |
| Raynaud’s phenomenon | 1159 | 15.9 | 1133 | 16.5 | 26 | 5.7 | 3.3 | 2.2–4.9 |
| ≥ 1 neuropathy | 1143 | 15.6 | 1077 | 15.7 | 66 | 14.3 | 1.1 | 0.9–1.5 |
| ≥ 1 autoimmune disease | 1156 | 15.8 | 1124 | 16.4 | 32 | 7.0 | 2.6 | 1.8–2.8 |
| Gastroparesis | 966 | 13.2 | 942 | 13.8 | 24 | 5.2 | 2.9 | 1.9–4.4 |
| Vasovagal syncope | 831 | 11.4 | 804 | 11.7 | 27 | 5.9 | 2.1 | 1.4–3.2 |
| Inappropriate sinus tachycardia | 850 | 11.6 | 824 | 12.0 | 26 | 5.7 | 2.3 | 1.5–3.4 |
| Mast cell activation syndrome | 777 | 10.6 | 755 | 11.0 | 22 | 4.8 | 2.5 | 1.6–3.8 |
CI, confidence interval.